Cadillac Optiq | |
---|---|
![]() | |
Overview | |
Manufacturer | General Motors SAIC-GM |
Production | 2023–present |
Assembly |
|
Designer | |
Body and chassis | |
Class | Compact luxury crossover SUV |
Body style | 5-door SUV |
Layout |
|
Platform | GM BEV3 |
Related | |
Powertrain | |
Electric motor | Permanent magnet Syncronus motor |
Power output |
|
Battery | 68.4 / 79.7 / 85 kWh 10-modules Ultium Lithium Tenary (NMC) |
Range | Maximum 600 km (373 mi) |
Dimensions | |
Wheelbase | 2,954 mm (116.3 in) |
Length | 4,822 mm (189.8 in) |
Width | 1,912 mm (75.3 in) |
Height | 1,642 mm (64.6 in) |
Curb weight | 2,220 kg (4,890 lb) |
The Cadillac Optiq is a battery electric Compact luxury crossover SUV to be marketed under the Cadillac subdivision of American automobile manufacturer General Motors and manufactured by SAIC-GM, a joint venture between the Chinese manufacturer Shanghai Automotive Industry Corporation (SAIC) and General Motors. It has been marketed in China since late 2023 and is to go on sale in North America in 2024.[3]
Overview
![](https://upload.wikimedia.org/wikipedia/commons/thumb/1/12/Cadillac_Optiq_002.jpg/220px-Cadillac_Optiq_002.jpg)
The Cadillac Optiq is scheduled to go on sale during the second half of 2023, and will later be marketed in North America in 2024.[4] It will be available in two trims that have an output of 150 kW and 180 kW respectively.[3] The car is intended to be a lower priced entry-level EV for the brand.[5]
References
- ^ "Instagram".
- ^ Buder, Moritz (October 10, 2022). "This Could be the Cadillac Optiq, and it Could Be a Performance Beast". topspeed.com. Retrieved March 1, 2024.
- ^ a b Opletal, Jiri (July 14, 2023). "Cadillac Optiq SUV is a new EV only for China". CarNewsChina.com. Retrieved July 14, 2023.
- ^ "2025 Cadillac Optiq Is the Lyriq's Smaller Electric-SUV Sibling". Car and Driver. November 17, 2023. Retrieved November 17, 2023.
- ^ Wayland, Michael (November 17, 2023). "Cadillac reveals its new entry-level EV, a compact crossover called the Optiq". CNBC. Retrieved November 17, 2023.